GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40338)

Analyse AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
P40338
Type
protein
Length
181 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x731d8ea2236F13759e0bE3C1C2bA23586AF10363
Molecule
Von hippel-lindau disease tumor suppressor
UniProt
P40338
Pockets
1 · best druggability 0.40

Structure

1 distinct chain · 27% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVon hippel-lindau disease tumor suppressorprotein18127% helix, 24% strandP40338

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.400.7422empty

Compared structures

  • 1HV2 · Solution structure of yeast elongin C in complex with a von hippel- lindau peptide · an experimental structure of the same protein · chain A against B, TM-score 0.08
  • 1HV2 · Solution structure of yeast elongin C in complex with a von hippel-lindau peptide · an experimental structure of the same protein · chain A against B, TM-score 0.08

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.